Thermo King and va-Q-tec are providing solutions to transport vaccines Fri May 07 08:41:10 CST 2021 Source: www.refindustry.com Collect Reading Volume: 772
Share to Weixin X Thermo King is leveraging its well-established partnership with va-Q-tec by preconditioning their temperature storage elements and containers with its Cold Storage Solutions to meet the exact temperature requirements for reliable vaccine distribution. va-Q-tec equipped the majority of their current 40 worldwide stations with Thermo King Magnum Plus and SuperFreezer refrigerated containers. These Thermo King containers can maintain stable temperature set-points between -70 degrees Celsius to + 30 degrees Celsius allowing va-Q-tec to precondition the temperature storage elements (also referred to as PCM ‘phase changing materials’) used in their passive containers and boxes to the precise temperature required by the pharmaceutical companies and en
From the lab to the jab: How BioNTech-Pfizer won vaccine race
Top Searches
From the lab to the jab: How BioNTech-Pfizer won vaccine race
AFP / Dec 30, 2020, 08:26 IST
FacebookTwitterLinkedinEMail
(Representative image)
BERLIN: It was over breakfast on the wintry morning of January 24 that Ozlem Tureci and her husband Ugur Sahin decided, we need to fire the starting gun on this .
Sahin had concluded from a publication describing coronavirus cases in Wuhan . that there was a high probability that a pandemic could be imminent , Tureci recounted.
The decision by the couple, founders of a small German company called BioNTech, gave birth to Operation Lightspeed in which the scientists in the company diverted all their resources from cancer therapy research to finding a vaccine to stop Covid-19.
From the lab to the jab: how BioNTech-Pfizer won the vaccine race japanherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from japanherald.com Daily Mail and Mail on Sunday newspapers.
The decision by the couple, founders of a small German company called BioNTech, gave birth to Operation Lightspeed in which the scientists in the company diverted all their resources from cancer therapy research to finding a vaccine to stop Covid-19.
As BioNTech and other pharmaceutical companies leapt into action in search of the winning formula, Germany s army of "Mittelstand" companies and other bigger manufacturing and logistics experts would soon prove crucial.